Search Results - "Visco Comandini, Ubaldo"
-
1
Liver transplantation from active COVID‐19 donors: A lifesaving opportunity worth grasping?
Published in American journal of transplantation (01-12-2021)“…COVID‐19 pandemic dramatically impacted transplantation landscape. Scientific societies recommend against the use of donors with active SARS‐CoV‐2 infection…”
Get full text
Journal Article -
2
Coordinated cellular and humoral immune responses after two‐dose SARS‐CoV2 mRNA vaccination in liver transplant recipients
Published in Liver international (01-01-2022)“…Limited data are available on risks and benefits of anti‐SARS‐CoV2 vaccination in solid organ transplant recipients, and weaker responses have been described…”
Get full text
Journal Article -
3
"Real world" efficacy of bulevirtide in HBV/HDV-related cirrhosis including people living with HIV: Results from the compassionate use programme at INMI Spallanzani in Rome, Italy
Published in HIV medicine (01-10-2023)“…We describe the preliminary results of bulevirtide compassionate use in patients with hepatitis B and delta virus (HBV/HDV)-related cirrhosis and clinically…”
Get full text
Journal Article -
4
Third dose of SARS‐CoV2 mRNA vaccination produces robust persistent cellular and humoral immune responses in liver transplant recipients
Published in Liver international (01-05-2023)“…Weaker responses have been described after two doses of anti‐SARS‐CoV2 vaccination in liver transplant recipients (LTRs). At the Italian National Institute for…”
Get full text
Journal Article -
5
Significance of detectable HCV RNA below the limit of quantification in patients treated with DAAs using standard and ultrasensitive protocols
Published in Journal of medical virology (01-07-2018)“…Predictive factors of HCV relapse after treatment with DAAs are poorly understood. In this study, we aimed to assess whether the residual viral load positivity…”
Get full text
Journal Article -
6
Lack of reduction in serum alpha‐fetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with hepatitis C virus‐related cirrhosis
Published in Journal of viral hepatitis (01-12-2018)“…Summary Risk of hepatocellular carcinoma (HCC) in hepatitis C virus cirrhotic patients treated with direct‐acting antiviral agents (DAA) is still debating. We…”
Get full text
Journal Article -
7
The Italian compassionate use of sofosbuvir in HCV patients waitlisted for liver transplantation: A national real‐life experience
Published in Liver international (01-04-2018)“…Background & Aims This study aimed to assess the real‐life clinical and virological outcomes of HCV waitlisted patients for liver transplantation (LT) who…”
Get full text
Journal Article -
8
Unawareness of HCV serostatus among persons newly diagnosed with HIV
Published in Journal of infection and public health (01-09-2019)“…Treatment of chronic HCV infection with direct acting antivirals can achieve high rates of sustained viral response in persons with HIV. In the perspective of…”
Get full text
Journal Article -
9
Liver sinusoidal endothelial cells (LSECs) modifications in patients with chronic hepatitis C
Published in Scientific reports (19-06-2019)“…The sinusoidal endothelial cells present in the liver (LSECs) are tipically characterized by the presence of pores (fenestrae). During some pathological…”
Get full text
Journal Article -
10
Contamination by hepatitis B and C viruses in the dialysis setting
Published in American journal of kidney diseases (01-09-2003)“…Background: Hepatitis virus infections continue to be a major concern in the dialysis setting. We studied levels of hepatitis B surface antigen (HBsAg) and…”
Get full text
Journal Article -
11
Phylogenetic and Phylodynamic Analysis of Delta Strains Circulating in Italy
Published in Viruses (23-08-2023)“…The hepatitis delta virus (HDV) exhibits high genetic and evolutionary variability and is classified into eight genotypes (HDV-1 to -8). HDV-1 is the most…”
Get full text
Journal Article -
12
Publisher Correction: Liver sinusoidal endothelial cells (LSECs) modifications in patients with chronic hepatitis C
Published in Scientific reports (24-01-2020)“…An amendment to this paper has been published and can be accessed via a link at the top of the paper…”
Get full text
Journal Article -
13
Analysis of HIV quasispecies and virological outcome of an HIV D+/R+ kidney-liver transplantation
Published in Virology journal (06-01-2022)“…Transplantation among HIV positive patients may be a valuable therapeutic intervention. This study involves an HIV D+/R+ kidney-liver transplantation, where…”
Get full text
Journal Article -
14
Hepatic Failure in COVID-19: Is Iron Overload the Dangerous Trigger?
Published in Cells (Basel, Switzerland) (04-05-2021)“…Liver injury in COVID-19 patients has progressively emerged, even in those without a history of liver disease, yet the mechanism of liver pathogenicity is…”
Get full text
Journal Article -
15
Humoral Immune Response after COVID-19 mRNA Vaccination in Patients with Liver Cirrhosis: A Prospective Real-Life Single Center Study
Published in Biomedicines (28-04-2023)“…Coronavirus-disease-2019 (COVID-19) mRNA vaccination effectively reduces mortality and morbidity in cirrhotic patients, but the immunogenicity and safety of…”
Get full text
Journal Article -
16
Sofosbuvir plus daclatasvir with or without ribavirin is safe and effective for post‐transplant hepatitis C recurrence and severe fibrosis and cirrhosis: A prospective study
Published in Clinical transplantation (01-02-2018)“…Background In 2012, an Italian Named Patient Program began for hepatitis C virus (HCV)‐infected liver transplant (LT) recipients with advanced fibrosis, before…”
Get full text
Journal Article -
17
Ultrasensitive HCV RNA Quantification in Antiviral Triple Therapy: New Insight on Viral Clearance Dynamics and Treatment Outcome Predictors
Published in PloS one (25-08-2016)“…Identifying the predictive factors of Sustained Virological Response (SVR) represents an important challenge in new interferon-based DAA therapies. Here, we…”
Get full text
Journal Article -
18
Daclatasvir, sofosbuvir with or without ribavirin for 24 weeks in hepatitis C genotype 3 cirrhosis: A real-life study
Published in Annals of hepatology (01-05-2019)“…AbstractIntroduction and aimCirrhotic patients with hepatitis C virus genotype 3 infection show unsatisfactory outcomes after 12 weeks’ treatment with direct…”
Get full text
Journal Article -
19
Prevention of hepatitis C recurrence by bridging sofosbuvir/ribavirin from pre‐ to post‐liver transplant: a real‐life strategy
Published in Liver international (01-05-2017)“…Background & Aims Hepatitis C virus (HCV) re‐infection following liver transplant (LT) is associated with reduced graft and patient survival. Before…”
Get full text
Journal Article -
20
Hepatocellular carcinoma with macrovascular invasion treated with yttrium-90 radioembolization prior to transplantation
Published in Hepatobiliary surgery and nutrition (01-02-2017)Get full text
Journal Article